Investment Summary

Advantage Capital Partners Invests In Cecil D

On May 1, 2021, growth capital firm Advantage Capital Partners invested in infrastructure company Cecil D

Investment Highlights
  • This is Advantage Capital Partners’ 1st transaction in the Infrastructure sector.
  • This is Advantage Capital Partners’ 308th transaction in the United States.
  • This is Advantage Capital Partners’ 19th transaction in Louisiana.

Investment Summary

Date 2021-05-01
Target Cecil D
Sector Infrastructure
Investor(s) Advantage Capital Partners
Deal Type Venture

Target

Cecil D

Alexandria, Louisiana, United States
Cecil D is a operated General Contractor specializing in the construction of Federal and State projects throughout the southeast. Cecil D is based in Alexandria, Louisiana.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Advantage Capital Partners

New Orleans, Louisiana, United States

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1992
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.


DEAL STATS #
Overall 312 of 329
Sector: Infrastructure M&A 1 of 1
Type: Venture M&A Deals 119 of 125
State: Louisiana M&A 19 of 21
Country: United States M&A 308 of 325
Year: 2021 M&A 17 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-16 Recursion Pharmaceuticals

Salt Lake City, Utah, United States

Recursion Pharmaceuticals is a drug discovery company. Recursion uses a novel drug screening platform to efficiently repurpose and reposition drugs to treat rare genetic diseases. Recursion’s novel drug screening platform combines experimental biology and bioinformatics in a massively parallel system to quickly and efficiently identify treatments for multiple rare genetic diseases. Recursion Pharmaceuticals was founded in 2013 and is based in Salt Lake City, Utah.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-19 Ability Insurance

Omaha, Nebraska, United States

Ability Insurance is a dedicated group of employees who share a common passion to serve long-term care (LTC) policyholders and claimants in an unrivaled manner. The company's associates are experts specializing in LTC insurance. Its staff is comprised of professionals empowered with information and enabled with experience to fulfill LTC contract's promises.

Sell $20M